Israel Englander’s BeOne Medicines Ltd ONC Stock Holding History

Israel Englander’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.56M	Buy	+12,500	New	+$3.68M	﹤0.01%	3317
2026 Q1	–	Sell	-20,000	Closed	-$6.08M	–	6538
2025 Q4	$6.08M	Sell	20,000 -30,000	-60%	-$9.82M	﹤0.01%	2797
2025 Q3	$17M	Buy	+50,000	New	+$15.2M	0.01%	1836
2023 Q4	–	Sell	-23,800	Closed	-$4.28M	–	6637
2023 Q3	$4.28M	Buy	+23,800	New	+$4.71M	﹤0.01%	2836
2022 Q2	–	Sell	-16,000	Closed	-$3.02M	–	7608
2022 Q1	$3.02M	Buy	16,000 +6,000	+60%	+$1.28M	﹤0.01%	3492
2021 Q4	$2.71M	Buy	+10,000	New	+$3.38M	﹤0.01%	3489
2020 Q2	–	Sell	-50,000	Closed	-$6.16M	–	4681
2020 Q1	$6.16M	Buy	+50,000	New	+$7.82M	0.01%	1177
2019 Q4	–	Sell	-50,000	Closed	-$6.12M	–	4699
2019 Q3	$6.12M	Buy	+50,000	New	+$6.64M	0.01%	1645
2019 Q2	–	Sell	-21,900	Closed	-$2.89M	–	4547
2019 Q1	$2.89M	Buy	+21,900	New	+$2.95M	﹤0.01%	2155
2018 Q2	–	Sell	-20,000	Closed	-$3.36M	–	4253
2018 Q1	$3.36M	Buy	+20,000	New	+$2.71M	﹤0.01%	2033

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Israel Englander's ONC Position: Q2 2026 in Review

Israel Englander increased its BeOne Medicines Ltd (ONC) stake by 165% in Q2 2026, buying an estimated $99.7M and bringing the position to 543,323 shares worth $155M. The position accounts for 0.06% of the portfolio, ranked #331.

Israel Englander first reported a position in ONC in Q1 2016 and has held it in 32 quarters since. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Israel Englander held 543,323 shares of BeOne Medicines Ltd worth $155M as of Q2 2026.
Israel Englander bought 338,477 BeOne Medicines Ltd shares in Q2 2026, an estimated $99.7M.
BeOne Medicines Ltd made up 0.06% of Israel Englander's portfolio in Q2 2026, its #331 holding.
Israel Englander first reported a position in BeOne Medicines Ltd in Q1 2016 and has held it in 32 quarters since.
282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.